Genotypic and Allelic Frequencies of GJB2 Variants and Features of Hearing Phenotypes in the Chinese Population of the Dongfeng-Tongji Cohort
by
,
Lanlai Yuan
1, 
Xiaohui Wang
1,
Xiaozhou Liu
1,
Sen Chen
1,
Weijia Kong
1,2,
Meian He
3,* and
Yu Sun
1,2,*
1
Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2
Institute of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
3
Department of Occupational and Environmental Health, Ministry of Education and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
*
Authors to whom correspondence should be addressed.
Genes 2023, 14(11), 2007; https://doi.org/10.3390/genes14112007
Submission received: 19 September 2023
/
Revised: 22 October 2023
/
Accepted: 24 October 2023
/
Published: 27 October 2023
(This article belongs to the Topic Advances in Genetics and Precision Medicine in Human Diseases)
Abstract
:Background: This study aimed to describe the distribution of the genotype and allele frequencies of GJB2 variants in the Chinese population of the Dongfeng Tongji cohort and to analyze the features of the hearing phenotype. Methods: We used data from 9910 participants in the Dongfeng Tongji cohort in 2013 and selected nine GJB2 variants. Pure tone audiometry was employed to measure hearing. Differences in genotype and allele frequencies were analyzed via chi-squared test or Fisher’s exact test. Results: Of the 9910 participants, 5742 had hearing loss. The genotype frequency of the GJB2 variant c.109G>A was statistically significantly distributed between the normal and impaired hearing groups, but not for the variant c.235delC. A higher frequency of the c.109G>A homozygous genotype was found in the hearing loss group (0.5%) than in the normal hearing group (0.1%). Patients with c.109G>A and c.235delC homozygous mutations exhibited varying degrees of hearing loss, mainly presenting sloping and flat audiogram shapes. Conclusions: A significant difference was found in the genotype frequency of the GJB2 variant c.109G>A between the case and control groups, but not in that of the variant c.235delC. Different degrees of hearing loss and various audiogram shapes were observed in patients with c.109G>A and c.235delC homozygous mutations.
1. Introduction
Hearing loss is a common sensory disorder affecting more than 1.5 billion people worldwide, including 430 million with moderate or severe hearing loss [1,2]. Hereditary factors or predispositions account for approximately 50% of hearing loss [3,4]. Genetic hearing loss includes syndromic and non-syndromic types, with marked genetic heterogeneity [5,6]. Of the genetic cases, about 70% are non-syndromic deafness, of which around 80% are inherited as an autosomal recessive trait [4]. To date, 124 genes have been identified for non-syndromic hearing loss and 77 for autosomal recessive non-syndromic hearing loss [7]. The most common cause of non-syndromic hearing loss is mutations in the gap junction protein beta 2 (GJB2) gene (OMIM: 121011), which encodes the gap junction protein connexin 26 (Cx26) on chromosome 13q12.11 [8,9,10].
Since hearing loss related to GJB2 was first described in 1997 [11,12], more than 300 pathogenic variants of GJB2 have been reported [10,12]. In different regions of the world, the spectrums and frequencies of mutations in GJB2 vary widely [12]. The mutant allele of c.35delG is prevalent in populations of Europe and the Middle East, c.235delC is common in East Asia, and p.W24X is mainly found in India [12]. In addition, c.167delT and p.R143W are found in Ashkenazim and Ghanaians, respectively [12]. The c.109G>A, a specific variant of GJB2, is also common among deaf patients in East Asia [12]. However, the classification of this missense variant has been controversial [13]. The c.109G>A variant was initially reported as a benign polymorphism because of its high prevalence among people with normal hearing [14]. Later, c.109G>A was identified as homozygous or in trans with known pathogenic GJB2 mutations in affected individuals [13,15,16]. Currently, c.109G>A is considered a pathogenic mutation with incomplete penetrance [13], and the homozygous mutation is associated with various hearing phenotypes [10,17]. Similarly, the other GJB2 variants show diverse phenotypes, ranging from mild to profound [8,18], which largely depend on the genotype [8,10,19]. Patients with biallelic “truncating” mutations that completely block protein expression generally have severe to profound hearing loss, whereas patients with at least one “non-truncating” mutant allele have a lower hearing threshold due to impaired but not inactivated protein function [8,10,19]. However, even among patients with the same genotype of the GJB2 mutation, auditory phenotypes show great variability [8,10,20]. Therefore, further investigation of genotype–phenotype correlations is needed to guide clinical evaluation and genetic counseling of patients with hearing loss associated with the GJB2 mutations.
Given the dominant role of GJB2 mutations in hearing loss and their genetic heterogeneity and phenotypic diversity, it is important to analyze the frequency distribution and genotype–phenotype correlation of GJB2 mutations in hearing loss patients for genetic diagnosis and counseling. This study aimed to: (1) analyze the frequencies of genotypes and alleles of GJB2 mutations in the Chinese population from the Dongfeng Tongji (DFTJ) cohort and (2) investigate audiogram shapes in patients with hearing loss with regard to different genotypes of c.109G>A and c.235delC mutations in the GJB2 gene.
2. Materials and Methods
2.1. Study Population
The DFTJ cohort is a prospective study launched in September 2008 in Shiyan City, Hubei Province, China, based on retired employees of Dongfeng Motor Corporation [21]. The baseline survey was conducted between September 2008 and June 2010, with subsequent follow-ups every five years [21]. Information on demographic characteristics, lifestyle, health status, and medical history was collected by trained interviewers using a standardized questionnaire. In addition, participants performed physical examinations and provided samples of peripheral venous blood after an overnight fast. A total of 27,009 participants completed baseline questionnaires, physical examinations, and blood sample collections. Between April and October 2013, 25,978 participants completed the first follow-up. Pure tone audiometry (PTA) was first added in 2013, with 11,513 participants in the baseline population undergoing the test [22]. The approval of the DFTJ cohort protocol was obtained from the Medical Ethics Committee of the School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, and Dongfeng General Hospital, Dongfeng Motor Corporation [21]. Written informed consent was obtained from each participant.
After the exclusion of 57 participants with invalid audiometric data and 1544 participants who lacked the genotype and failed quality control, this study included 9912 participants with complete data on nine GJB2 mutations and audiometry. After those participants missing the age variable data (n = 2) were removed, 9910 participants were used for the final analysis.
2.2. Measurement of Hearing
In a special soundproof room at Dongfeng General Hospital, participants underwent pure tone tests administered by professional audiologists using a calibrated pure tone audiometer (Micro-DSP ZD21, Micro DSP Technology Co., Ltd., Chengdu, China) after an otological examination. Air conduction thresholds at 0.5, 1, 2, 4, and 8 kHz were recorded for each ear and coded as a maximum when the maximum was unresponsive [23]. Hearing loss was defined as an average threshold at 0.5, 1, 2, and 4 kHz (PTA0.5–4 kHz) greater than 25 decibels of hearing level (dB HL) in the better ear [24]. The severity of hearing loss was categorized as mild (25 dB HL < PTA0.5–4 kHz ≤ 40 dB HL), moderate (40 dB HL < PTA0.5–4 kHz ≤ 60 dB HL), and severe–profound (PTA0.5–4 kHz > 60 dB HL).
Based on Liu’s [20] classification criteria, the audiogram shapes of 5742 participants with hearing loss were classified as follows: sloping, where the difference between the mean thresholds at 4 kHz and 8 kHz and the mean thresholds at 0.5 kHz and 1 kHz was greater than 15 dB HL; flat, where the difference between the thresholds at 0.5 to 8 kHz was less than 15 dB HL; mid-frequency U-shaped, where the difference between the worst hearing thresholds at mid-frequency and those at lower and higher frequencies was greater than 15 dB HL; ascending, where the difference between the low-frequency thresholds and the high-frequency thresholds was greater than 15 dB HL; and residual, where only residual hearing was present at lower frequencies. Those not belonging to any of the above audiogram shapes were classified as “other”. Due to the relatively small sample size of patients with mid-frequency U-shaped (0.8%) and ascending (3.7%) hearing loss, the two types were combined into the “special” type.
2.3. Genotyping
For the purpose of genetic analysis related to hearing loss, nine common GJB2 mutations in the Chinese population were selected. Nine GJB2 variants or single nucleotide polymorphisms were selected as follows: c.11G>A (rs111033222), c.79G>A (rs2274084), c.*84T>C (rs3751385), c.109G>A (rs72474224), c.235delC (rs80338943), c.341A>G (rs2274083), c.368C>A (rs111033188), c.571T>C (rs397516878), and c.608T>C (rs76838169). These variants were genotyped in a genome-wide association study scan of the DFTJ cohort using Affymetrix Genome-Wide Human SNP Array 6.0 chips (Affymetrix China Inc., Shanghai, China)and Illumina Infinium Omni Zhong Hua-8 Chips (Illumina Trading Co., Ltd., Shanghai, China) [25]. In brief, these SNPs were successfully genotyped after quality control, excluding any SNPs with missing call rate > 5%, minor allele frequency < 1%, and p value of Hardy–Weinberg equilibrium < 10−5. There were 703,302 SNPs in the Illumina dataset and 549,196 in the Affymetrix dataset. Genotypes of markers in the Illumina and Affymetrix datasets were imputed separately using the 1000 Genomes Project ALL Phase 3 Integrated Release Version 5 haplotypes as a reference panel. Detailed descriptions of the genotyping and quality control processes are available elsewhere [26,27].
2.4. Statistical Analysis
The categorical variables were expressed as numbers with percentages, and the continuous variables as means with standard deviations. Comparisons of differences in genotype and allele frequencies between groups were conducted using the chi-squared test or Fisher’s exact test. The threshold for significance was set at a two-sided p-value of less than 0.05. All statistical analyses were carried out using R software (version 4.2.3, R Foundation for Statistical Computing, Vienna, Austria).
3. Results
3.1. Basic Characteristics of the Study Population
Table 1 shows the characteristics of the total samples. A total of 9910 participants were included in the study, with a gender makeup of 52.4% (n = 5197) female and 47.6% (n = 4713) male. The mean age was 67.2 years. In total, 5742 participants had hearing loss, including 66.3% (n = 3806) mild, 27.5% (n = 1581) moderate, and 6.2% (n = 355) severe to profound. In addition, the mean ages of the controls and patients were 63.9 (7.0) and 69.7 (7.1) years, respectively.
3.2. Frequencies of the Genotypes and Alleles of the Mutations in the GJB2 Gene
Table 2 shows the genotype and allele frequencies of the nine mutations of the GJB2 gene in the cohort and between the hearing-impaired and normal groups. Based on the variant annotation in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/, accessed on 13 May 2023), two variants are reported as pathogenic variants (c.109G>A and c.235delC); five are benign or likely benign variants (c.79G>A, c.*84T>C, c.341A>G, c.368C>A, and c.608T>C); one is uncertain (c.571T>C); and the last has a conflicting interpretation of pathogenicity (c.11G>A). We found a significant difference (p-value < 0.001) in the genotype frequency distribution of c.109G>A between the case and control groups (Table 2). Compared to the normal hearing group, the frequency of homozygous genotype was higher in the hearing loss group (0.1% in the normal hearing group and 0.5% in the hearing loss group). The homozygous mutation in c.109G>A affected a wide range of frequencies, and the detailed characteristics and pure tone thresholds of the 31 participants with homozygous genotypes in the cohort are shown in Table 3. The frequency distribution of p.V37 I alleles was nearly the same between the case and control groups (6.0% in controls and 6.3% in the hearing loss group), but not significantly different. Furthermore, the frequency of the c.109G>A homozygous genotype increased with hearing threshold in 5742 participants with hearing loss (0.4% mild, 0.7% moderate, and 0.8% severe–profound) (Figure 1), but no significant difference was observed between groups (p = 0.369). Likewise, no statistical difference was found for the frequency distribution of c.109G>A alleles across hearing loss severity groups (p = 0.274) (Figure 2).
However, regarding c.235delC, the most common mutation reported in the Chinese population with hearing loss, the frequency distributions of its genotype and allele were not found to differ significantly between controls and cases (Table 2). The carrier frequency of c.235delC was 1.1% in the general population controls (Table 2). Among the 5742 patients with hearing loss, the carrier frequency was 1.4%, and only two patients were identified with homozygous mutations (Table 2), with proportions of 0.1% and 0.3% in moderate and severe–profound hearing loss, respectively (Figure 1). Additionally, there was no significant difference in the allele frequency of c.235delC between the different hearing loss severity groups (p = 0.661) (Figure 2).
Moreover, among the five benign variants, we found statistically significant differences in the genotype and allele frequencies of c.*84T>C between case and control groups (Table 2). The allele frequency of c.*84T>C was comparable between the case and control groups (53.9% in the control group and 52.5% in the hearing loss group). A similar distribution was observed for the other four benign variants (c.79G>A, c.341A>G, c.368C>A, and c.608T>C) (Table 2). There were no statistical differences in genotype and allele frequencies for the remaining two variants (c.11G>A and c.571T>C) (Table 2).
3.3. Distribution of Audiogram Shapes for the Different Genotypes of rs72474224 (c.109G>A) and rs80338943 (c.235delC)
Figure 3a shows the distribution of audiogram shapes in the overall hearing loss group: 66.6% were sloping, 11.6% were flat, 4.5% were special, 6.7% were residual, and 10.6% were other. We analyzed the audiogram shape distributions of the two pathogenic variants (c.109G>A, and c.235delC) under different genotypes. As shown in Figure 3b, the c.109G>A and c.235delC variants presented various audiogram shapes, mainly showing sloping and flat types. The proportions of the sloping type in the c.109G>A heterozygous and homozygous genotypes were 70% and 82.1%, and the proportions of the flat type were 10% and 7.1%. For the c.235delC variant, the proportions of the sloping phenotype were 66% in the heterozygous genotypes and 100% in the homozygous genotypes; the flat phenotype was 14.4% in the heterozygous genotype.
4. Discussion
In this study of 9910 participants from the DFTJ cohort, we described an overview of the genotype and allele frequency distributions of nine variants with the GJB2 gene and analyzed the audiogram phenotypic profiles of two pathogenic variants for the hearing loss group. A significant difference in genotype frequencies between cases and controls was observed for the variants c.*84T>C and c.109G>A, while the other seven variants (including c.235delC) were not statistically different between cases and controls. Homozygous mutations in c.109G>A and c.235delC showed different degrees of hearing loss and various shapes of audiogram, mainly sloping and flat. This study was a large-scale population analysis of GJB2-related variants (including 4168 participants with normal hearing and 5742 patients with hearing loss), and contained objective pure tone audiometric measurements that could effectively characterize the hearing phenotype.
Consistent with our expectations, we found that the genotype frequencies of the c.109G>A variant in GJB2 were statistically significantly distributed between cases and controls. The frequency of homozygous genotype in the hearing impaired group was 0.5%, lower than that reported in other Chinese populations in a recent study [17], where c.109G>A homozygous genotypes accounted for 2.6% of patients with hearing loss (there were eleven c.109G>A homozygous genotypes in the eighty-eight patients with mild to moderate hearing loss and fourteen in the eight hundred and fifty-seven patients with severe to profound hearing loss). A possible explanation for this difference could be the different populations included. The age of the subjects in our study was generally much older, which might not exclude the contribution of aging to the hearing loss phenotype. In addition, we observed that the allele frequencies of c.109G>A were approximately equal between the normal and impaired hearing groups, with no significant difference. This might be because most of the alleles were contributed by unaffected heterozygote carriers, as observed in our study where the proportion of c.109G>A heterozygotes approximated between control and case groups (Table 2). Accordingly, it is more appropriate to compare genotype frequencies rather than allele frequencies in case and control analyses to interpret the variants related to autosomal recessive inheritance patterns in the GJB2 gene [13]. In agreement with several previous studies [10,17,28], we observed that patients with the c.109G>A homozygous genotype displayed different levels of hearing loss. Notably, Chai et al. further investigated potentially pathogenic variants in fourteen patients with severe to profound hearing loss of the c.109G>A homozygous genotype, and they identified another pathogenic variant of CDH23 coexisting with the c.109G>A homozygous mutation in one patient [17]. Therefore, when c.109G>A homozygous mutations are identified in patients with severe to profound hearing loss, there may be concurrent mutations in other genes or other alternative causes, such as infection or aging [13,17,28]. However, because of the lack of such data, alternative etiologies of c.109G>A homozygous mutations in patients with severe to profound hearing loss were not investigated in our study, and further studies are needed to elucidate them.
The c.235delC variant has been reported to be the most prevalent GJB2-associated variant in Chinese patients with hearing loss [4,12,29,30]. In addition, Dai et al. [29] reported that the frequency distributions of 235delC homozygous and heterozygous genotypes in patients with hearing loss varied significantly in different regions of China, ranging from 0% to 14.7% for the homozygous genotype and 1.7% to 16.1% for the heterozygous genotype. In general, the 235delC variant is more commonly found in northern China [12]. In our study, we observed two hearing-impaired patients with c.235delC homozygous genotypes, who showed moderate and severe to profound hearing loss, respectively. Participants in the DFTJ cohort were retired employees of Dongfeng Motor Corporation who had normal hearing before beginning work. However, it should be noted that individuals with severe hearing loss would not be hired. This restriction on hearing performance might explain the inconsistent frequency of c.235delC homozygous mutations observed in our study compared to other studies. The 235delC variant in the GJB2 gene causes a frameshift mutation that prematurely terminates translation and produces a non-functional gap junction protein [31,32]. Patients with the c.235delC homozygous genotype usually present with severe to profound prelingual hearing loss [20,33,34]. However, other studies have shown that patients with the c.235delC homozygous mutation also show mild to moderate hearing phenotypes [30,34]. Consistent with these findings, one of the patients in our study with the c.235delC homozygous genotype had moderate hearing loss, suggesting that the hearing phenotype of patients with the c.235delC homozygous mutation was diverse.
We found that the genotype and allele frequencies of c.*84T>C were statistically different between the normal and impaired hearing groups. The c.*84T>C is located in the 3′UTR region of the GJB2 gene and has been identified as a benign variant. Technological advances in sequencing and many other assays have facilitated the elucidation of the non-coding genome [35]. Many noncoding elements have been found to be linked to hearing loss, and the identification of non-coding variants in hearing loss is expected to improve diagnostic rates [35]. The genotype and allele frequencies of the c.*84T>C variant reported in our study may provide a molecular epidemiologic basis for future studies on non-coding region variants. In addition, two previous studies reported a significant association of the c.*84T>C with noise-induced hearing loss [36]. We observed that the allele frequencies of four benign variants (c.79G>A, c.341A>G, c.368C>A, and c.608T>C) were similar between cases and controls, whereas another study reported that their allele frequencies were greater in controls than in patients [5].
In agreement with a previous study [10], the audiogram shapes of the c.109G>A and c.235delC variants presented various audiometric configurations in this study, with a dominance of sloping and flat types. Similarly, Liu et al. found that audiogram shapes in most patients with GJB2-related hearing loss were generally residual, sloping, or flat, but similar to those observed in hearing impaired patients without the GJB2 mutation, suggesting a possible poor correlation between the type of GJB2 mutation and audiogram shape [20].
The limitations of this study should also be considered. First, the participants were from a single cohort and might not be representative of the general Chinese population, which limited the generalizability of the results. Second, other pathogenic variants in GJB2 were not included in the study. Finally, this study also did not consider the case of compound heterozygotes in the GJB2 gene or in combination with other genes, which requires further research.
5. Conclusions
To sum up, we observed a statistically significant distribution of genotype frequencies of the GJB2 variants c.*84T>C and c.109G>A between cases and controls in a Chinese population in the large-scale DFTJ cohort, but not for the c.235delC variant. Patients with c.109G>A and c.235delC homozygous mutations exhibited diverse hearing loss severities and audiogram shapes. These findings could provide evidence for genetic diagnosis and counseling for hearing loss.
Author Contributions
Y.S., W.K., L.Y., S.C., X.W. and X.L. designed the study. L.Y. analyzed the data and prepared the original draft. Y.S., M.H., W.K., L.Y., S.C., X.W. and X.L. revised and edited the paper. Y.S., M.H. and W.K. supervised the work. Y.S. acquired funding for the work. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the Innovative Research Groups of Hubei Province (No. 2023AFA038), the National Natural Science Foundation of China (No. 82071058), and the National Key Research and Development Program of China (No. 2021YFF0702303).
Institutional Review Board Statement
All procedures conducted in this study involving human participants were in accordance with the Declaration of Helsinki, and approved by the Medical Ethics Committee of the School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, and Dongfeng General Hospital, Dongfeng Motor Corporation (Approval No. 2008–03 and 2012–10).
Informed Consent Statement
Written informed consent was obtained from each participant.
Data Availability Statement
Requests may be addressed to the corresponding authors.
Acknowledgments
The contributions of all the participants, the staff of the Dongfeng Central Hospital, and all the members of the study team are greatly appreciated.
Conflicts of Interest
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Abbreviations
DFTJ, Dongfeng Tongji; PTA, Pure tone audiometry; SD, Standard deviation; SNPs, Single nucleotide polymorphisms.
References
- WHO. World Report on Hearing; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
- GBD 2019 Hearing Loss Collaborators. Hearing loss prevalence and years lived with disability, 1990–2019: Findings from the Global Burden of Disease Study 2019. Lancet 2021, 397, 996–1009. [Google Scholar] [CrossRef]
- Morton, N.E. Genetic epidemiology of hearing impairment. Ann. N. Y. Acad. Sci. 1991, 630, 16–31. [Google Scholar] [CrossRef]
- Cheng, H.B.; Chen, Z.B.; Wei, Q.J.; Lu, Y.J.; Xing, G.Q.; Cao, X. Single nucleotide polymorphisms and haplotypes analysis of DFNB1 locus in Chinese sporadic hearing impairment population. Chin. Med. J. 2009, 122, 1549–1553. [Google Scholar]
- Dai, P.; Yu, F.; Han, B.; Liu, X.; Wang, G.; Li, Q.; Yuan, Y.; Liu, X.; Huang, D.; Kang, D.; et al. GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment. J. Transl. Med. 2009, 7, 26. [Google Scholar] [CrossRef] [PubMed]
- Grillo, A.P.; de Oliveira, F.M.; de Carvalho, G.Q.; Medrano, R.F.; da Silva-Costa, S.M.; Sartorato, E.L.; de Oliveira, C.A. Single nucleotide polymorphisms of the GJB2 and GJB6 genes are associated with autosomal recessive nonsyndromic hearing loss. Biomed. Res. Int. 2015, 2015, 318727. [Google Scholar] [CrossRef] [PubMed]
- Van Camp, G.; Smith, R.J.H. Hereditary Hearing Loss Homepage. Available online: https://hereditaryhearingloss.org (accessed on 16 September 2023).
- Snoeckx, R.L.; Huygen, P.L.; Feldmann, D.; Marlin, S.; Denoyelle, F.; Waligora, J.; Mueller-Malesinska, M.; Pollak, A.; Ploski, R.; Murgia, A.; et al. GJB2 mutations and degree of hearing loss: A multicenter study. Am. J. Hum. Genet. 2005, 77, 945–957. [Google Scholar] [CrossRef] [PubMed]
- Morton, C.C.; Nance, W.E. Newborn hearing screening—A silent revolution. N. Engl. J. Med. 2006, 354, 2151–2164. [Google Scholar] [CrossRef] [PubMed]
- Chen, P.Y.; Lin, Y.H.; Liu, T.C.; Lin, Y.H.; Tseng, L.H.; Yang, T.H.; Chen, P.L.; Wu, C.C.; Hsu, C.J. Prediction Model for Audiological Outcomes in Patients with GJB2 Mutations. Ear Hear. 2020, 41, 143–149. [Google Scholar] [CrossRef]
- Kelsell, D.P.; Dunlop, J.; Stevens, H.P.; Lench, N.J.; Liang, J.N.; Parry, G.; Mueller, R.F.; Leigh, I.M. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997, 387, 80–83. [Google Scholar] [CrossRef] [PubMed]
- Chan, D.K.; Chang, K.W. GJB2-associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope 2014, 124, E34–E53. [Google Scholar] [CrossRef] [PubMed]
- Shen, J.; Oza, A.M.; Del Castillo, I.; Duzkale, H.; Matsunaga, T.; Pandya, A.; Kang, H.P.; Mar-Heyming, R.; Guha, S.; Moyer, K.; et al. Consensus interpretation of the p.Met34Thr and p.Val37Ile variants in GJB2 by the ClinGen Hearing Loss Expert Panel. Genet. Med. Off. J. Am. Coll. Med. Genet. 2019, 21, 2442–2452. [Google Scholar] [CrossRef] [PubMed]
- Kelley, P.M.; Harris, D.J.; Comer, B.C.; Askew, J.W.; Fowler, T.; Smith, S.D.; Kimberling, W.J. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am. J. Hum. Genet. 1998, 62, 792–799. [Google Scholar] [CrossRef]
- Abe, S.; Usami, S.; Shinkawa, H.; Kelley, P.M.; Kimberling, W.J. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J. Med. Genet. 2000, 37, 41–43. [Google Scholar] [CrossRef] [PubMed]
- Wilcox, S.A.; Saunders, K.; Osborn, A.H.; Arnold, A.; Wunderlich, J.; Kelly, T.; Collins, V.; Wilcox, L.J.; McKinlay Gardner, R.J.; Kamarinos, M.; et al. High frequency hearing loss correlated with mutations in the GJB2 gene. Hum. Genet. 2000, 106, 399–405. [Google Scholar] [CrossRef]
- Chai, Y.; Chen, D.; Sun, L.; Li, L.; Chen, Y.; Pang, X.; Zhang, L.; Wu, H.; Yang, T. The homozygous p.V37I variant of GJB2 is associated with diverse hearing phenotypes. Clin. Genet. 2015, 87, 350–355. [Google Scholar] [CrossRef]
- Xiang, J.; Sun, X.; Song, N.; Ramaswamy, S.; Abou Tayoun, A.N.; Peng, Z. Comprehensive interpretation of single-nucleotide substitutions in GJB2 reveals the genetic and phenotypic landscape of GJB2-related hearing loss. Hum. Genet. 2023, 142, 33–43. [Google Scholar] [CrossRef]
- Chan, D.K.; Schrijver, I.; Chang, K.W. Connexin-26-associated deafness: Phenotypic variability and progression of hearing loss. Genet. Med. Off. J. Am. Coll. Med. Genet. 2010, 12, 174–181. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.Z.; Pandya, A.; Angeli, S.; Telischi, F.F.; Arnos, K.S.; Nance, W.E.; Balkany, T. Audiological features of GJB2 (connexin 26) deafness. Ear Hear. 2005, 26, 361–369. [Google Scholar] [CrossRef]
- Wang, F.; Zhu, J.; Yao, P.; Li, X.; He, M.; Liu, Y.; Yuan, J.; Chen, W.; Zhou, L.; Min, X.; et al. Cohort Profile: The Dongfeng-Tongji cohort study of retired workers. Int. J. Epidemiol. 2013, 42, 731–740. [Google Scholar] [CrossRef]
- Wang, D.; Zhou, Y.; Ma, J.; Xiao, L.; Cao, L.; Zhou, M.; Kong, W.; Wang, Z.; Li, W.; He, M.; et al. Association between shift work and hearing loss: The Dongfeng-Tongji cohort study. Hear. Res. 2019, 384, 107827. [Google Scholar] [CrossRef]
- Wang, D.; Xiao, Y.; Feng, X.; Wang, B.; Li, W.; He, M.; Zhang, X.; Yuan, J.; Yi, G.; Chen, Z.; et al. Association of occupational noise exposure, bilateral hearing loss with atherosclerotic cardiovascular disease risk in Chinese adults. Int. J. Hyg. Environ. Health 2021, 235, 113776. [Google Scholar] [CrossRef] [PubMed]
- Report of the Informal Working Group on Prevention of Deafness and Hearing Impairment Programme Planning, Geneva, 18–21 June 1991. Available online: https://apps.who.int/iris/handle/10665/58839 (accessed on 16 September 2023).
- Jiang, J.; He, S.; Liu, K.; Yu, K.; Long, P.; Xiao, Y.; Liu, Y.; Yu, Y.; Wang, H.; Zhou, L.; et al. Multiple plasma metals, genetic risk and serum complement C3, C4: A gene-metal interaction study. Chemosphere 2022, 291, 132801. [Google Scholar] [CrossRef]
- He, M.; Wu, C.; Xu, J.; Guo, H.; Yang, H.; Zhang, X.; Sun, J.; Yu, D.; Zhou, L.; Peng, T.; et al. A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk. Gut 2014, 63, 143–151. [Google Scholar] [CrossRef] [PubMed]
- Long, P.; Liu, X.; Li, J.; He, S.; Chen, H.; Yuan, Y.; Qiu, G.; Yu, K.; Liu, K.; Jiang, J.; et al. Circulating folate concentrations and risk of coronary artery disease: A prospective cohort study in Chinese adults and a Mendelian randomization analysis. Am. J. Clin. Nutr. 2020, 111, 635–643. [Google Scholar] [CrossRef]
- Huang, S.; Huang, B.; Wang, G.; Yuan, Y.; Dai, P. The Relationship between the p.V37I Mutation in GJB2 and Hearing Phenotypes in Chinese Individuals. PLoS ONE 2015, 10, e0129662. [Google Scholar] [CrossRef] [PubMed]
- Dai, P.; Yu, F.; Han, B.; Yuan, Y.; Li, Q.; Wang, G.; Liu, X.; He, J.; Huang, D.; Kang, D.; et al. The prevalence of the 235delC GJB2 mutation in a Chinese deaf population. Genet. Med. Off. J. Am. Coll. Med. Genet. 2007, 9, 283–289. [Google Scholar] [CrossRef]
- Yu, X.; Lin, Y.; Xu, J.; Che, T.; Li, L.; Yang, T.; Wu, H. Molecular epidemiology of Chinese Han deaf patients with bi-allelic and mono-allelic GJB2 mutations. Orphanet J. Rare Dis. 2020, 15, 29. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.Z.; Xia, X.J.; Ke, X.M.; Ouyang, X.M.; Du, L.L.; Liu, Y.H.; Angeli, S.; Telischi, F.F.; Nance, W.E.; Balkany, T.; et al. The prevalence of connexin 26 (GJB2) mutations in the Chinese population. Hum. Genet. 2002, 111, 394–397. [Google Scholar] [CrossRef]
- Lin, Y.F.; Lin, H.C.; Tsai, C.L.; Hsu, Y.C. GJB2 mutation spectrum in the Taiwanese population and genotype-phenotype comparisons in patients with hearing loss carrying GJB2 c.109G>A and c.235delC mutations. Hear. Res. 2022, 413, 108135. [Google Scholar] [CrossRef]
- Zhao, F.F.; Ji, Y.B.; Wang, D.Y.; Lan, L.; Han, M.K.; Li, Q.; Zhao, Y.; Rao, S.; Han, D.; Wang, Q.J. Phenotype-genotype correlation in 295 Chinese deaf subjects with biallelic causative mutations in the GJB2 gene. Genet. Test. Mol. Biomark. 2011, 15, 619–625. [Google Scholar] [CrossRef]
- Wang, H.; Gao, Y.; Guan, J.; Lan, L.; Yang, J.; Xiong, W.; Zhao, C.; Xie, L.; Yu, L.; Wang, D.; et al. Phenotypic Heterogeneity of Post-Lingual and/or Milder Hearing Loss for the Patients with the GJB2 c.235delC Homozygous Mutation. Front. Cell Dev. Biol. 2021, 9, 647240. [Google Scholar] [CrossRef] [PubMed]
- Avraham, K.B.; Khalaily, L.; Noy, Y.; Kamal, L.; Koffler-Brill, T.; Taiber, S. The noncoding genome and hearing loss. Hum. Genet. 2022, 141, 323–333. [Google Scholar] [CrossRef] [PubMed]
- Miao, L.; Ji, J.; Wan, L.; Zhang, J.; Yin, L.; Pu, Y. An overview of research trends and genetic polymorphisms for noise-induced hearing loss from 2009 to 2018. Environ. Sci. Pollut. Res. Int. 2019, 26, 34754–34774. [Google Scholar] [CrossRef] [PubMed]
Figure 1.
Frequency distribution of the genotypes for rs72474224 (c.109G>A) and rs80338943 (c.235delC) in the GJB2 gene across hearing loss severity groups. Note: The genotypes of wild, heterozygous, and homozygous for rs72474224 and rs80338943 are: C/C, T/C, and T/T; and AG/AG, A/AG, and A/A, respectively. The distribution of the genotypes of rs72474224 and rs80338943 among different hearing loss severity groups was tested using Fisher’s exact test, with p = 0.369 and p = 0.091, respectively.
Figure 1.
Frequency distribution of the genotypes for rs72474224 (c.109G>A) and rs80338943 (c.235delC) in the GJB2 gene across hearing loss severity groups. Note: The genotypes of wild, heterozygous, and homozygous for rs72474224 and rs80338943 are: C/C, T/C, and T/T; and AG/AG, A/AG, and A/A, respectively. The distribution of the genotypes of rs72474224 and rs80338943 among different hearing loss severity groups was tested using Fisher’s exact test, with p = 0.369 and p = 0.091, respectively.
Figure 2.
Frequency distribution of the alleles for rs72474224 (c.109G>A) and rs80338943 (c.235delC) in the GJB2 gene across hearing loss severity groups. Note: The wild-type and mutant alleles for rs72474224 and rs80338943 are as follows: C and T; and AG as well as A, respectively. The distribution of the alleles of rs72474224 and rs80338943 in different hearing loss severity groups was tested using the chi-squared test, and p values were: p = 0.274; and p = 0.661, respectively.
Figure 2.
Frequency distribution of the alleles for rs72474224 (c.109G>A) and rs80338943 (c.235delC) in the GJB2 gene across hearing loss severity groups. Note: The wild-type and mutant alleles for rs72474224 and rs80338943 are as follows: C and T; and AG as well as A, respectively. The distribution of the alleles of rs72474224 and rs80338943 in different hearing loss severity groups was tested using the chi-squared test, and p values were: p = 0.274; and p = 0.661, respectively.
Figure 3.
The audiogram shapes (a) in 5742 participants with hearing loss and (b) in the different genotypes of rs72474224 (c.109G>A) and rs80338943 (c.235delC). Note: The genotypes of wild, heterozygous, and homozygous for rs72474224 and rs80338943 are: C/C, T/C and T/T; and AG/AG, A/AG, and A/A, respectively. The distribution of the types of audiogram in different genotypes of rs72474224 and rs80338943 was tested using Fisher’s exact test, and p values were: p = 0.324, and p = 0.576, respectively.
Figure 3.
The audiogram shapes (a) in 5742 participants with hearing loss and (b) in the different genotypes of rs72474224 (c.109G>A) and rs80338943 (c.235delC). Note: The genotypes of wild, heterozygous, and homozygous for rs72474224 and rs80338943 are: C/C, T/C and T/T; and AG/AG, A/AG, and A/A, respectively. The distribution of the types of audiogram in different genotypes of rs72474224 and rs80338943 was tested using Fisher’s exact test, and p values were: p = 0.324, and p = 0.576, respectively.
Table 1.
Characteristics of overall participants.
| Characteristic | Total (n = 9910) |
|---|---|
| Age, mean (SD), years | 67.2 (7.6) |
| Age group (%) | |
| <60 | 1548 (15.6) |
| 60–69 | 4765 (48.1) |
| 70–79 | 3054 (30.8) |
| ≥80 | 543 (5.5) |
| Gender (%) | |
| Female | 5197 (52.4) |
| Male | 4713 (47.6) |
| Severity of hearing loss (%) | |
| Normal | 4168 (42.1) |
| Mild | 3806 (38.4) |
| Moderate | 1581 (16.0) |
| Severe-profound | 355 (3.6) |
Abbreviations: SD, standard deviation. Data were expressed as mean (SD) for continuous variables and number (percentage) for categorical variables.
Table 2.
Frequency distribution of genotypes and alleles of single nucleotide polymorphisms in the GJB2 gene.
Table 2.
Frequency distribution of genotypes and alleles of single nucleotide polymorphisms in the GJB2 gene.
| SNPs | Nucleotide Change | Protein Change | Clinical Significance | Overall (n = 9910) | Hearing Loss | p Value | |
|---|---|---|---|---|---|---|---|
| Control Group (n = 4168) | Patients Group (n = 5742) | ||||||
| rs111033222 | c.11G>A | p.G4D | Conflicting | ||||
| Genotype | C/C | 9854 (99.4) | 4143 (99.4) | 5711 (99.5) | 0.797 a | ||
| T/C | 56 (0.6) | 25 (0.6) | 31 (0.5) | ||||
| Allele | C | 19,764 (99.7) | 8311 (99.7) | 11,453 (99.7) | 0.797 a | ||
| T | 56 (0.3) | 25 (0.3) | 31 (0.3) | ||||
| rs2274084 | c.79G>A | p.V27I | Benign | ||||
| Genotype | C/C | 4391 (44.3) | 1854 (44.5) | 2537 (44.2) | 0.680 a | ||
| T/C | 4518 (45.6) | 1906 (45.7) | 2612 (45.5) | ||||
| T/T | 1001 (10.1) | 408 (9.8) | 593 (10.3) | ||||
| Allele | C | 13,300 (67.1) | 5614 (67.3) | 7686 (66.9) | 0.546 a | ||
| T | 6520 (32.9) | 2723 (32.7) | 3798 (33.1) | ||||
| rs3751385 | c.*84T>C | - | Benign | ||||
| Genotype | A/A | 2157 (21.8) | 850 (20.4) | 1307 (22.8) | 0.017a | ||
| A/G | 4985 (50.3) | 2142 (51.4) | 2843 (49.5) | ||||
| G/G | 2768 (27.9) | 1176 (28.2) | 1592 (27.7) | ||||
| Allele | A | 9299 (46.9) | 3842 (46.1) | 5457 (47.5) | 0.048 a | ||
| G | 10,521 (53.1) | 4494 (53.9) | 6027 (52.5) | ||||
| rs72474224 | c.109G>A | p.V37I | Pathogenic | ||||
| Genotype | C/C | 8718 (88.0) | 3674 (88.1) | 5044 (87.8) | <0.001 b | ||
| T/C | 1161 (11.7) | 491 (11.8) | 670 (11.7) | ||||
| T/T | 31 (0.3) | 3 (0.1) | 28 (0.5) | ||||
| Allele | C | 18,597 (93.8) | 7839 (94.0) | 10,758 (93.7) | 0.313 a | ||
| T | 1223 (6.2) | 497 (6.0) | 726 (6.3) | ||||
| rs80338943 | c.235delC | p.Leu79fs | Pathogenic | ||||
| Genotype | AG/AG | 9665 (97.5) | 4078 (97.8) | 5587 (97.3) | 0.118 b | ||
| A/AG | 243 (2.5) | 90 (2.2) | 153 (2.7) | ||||
| A/A | 2 (0.02) | 0 (0.0) | 2 (0.03) | ||||
| Allele | AG | 19,573 (98.8) | 8246 (98.9) | 11,327 (98.6) | 0.083 a | ||
| A | 247 (1.2) | 90 (1.1) | 157 (1.4) | ||||
| rs2274083 | c.341A>G | p.E114G | Benign/Likely benign | ||||
| Genotype | T/T | 5284 (53.3) | 2249 (54.0) | 3035 (52.9) | 0.423 a | ||
| C/T | 4025 (40.6) | 1678 (40.3) | 2347 (40.9) | ||||
| C/C | 601 (6.1) | 241 (5.8) | 360 (6.3) | ||||
| Allele | T | 14,593 (73.6) | 6176 (74.1) | 8417 (73.3) | 0.216 a | ||
| C | 5227 (26.3) | 2160 (25.9) | 3067 (26.7) | ||||
| rs111033188 | c.368C>A | p.T123N | Benign/Likely benign | ||||
| Genotype | G/G | 9828 (99.2) | 4134 (99.2) | 5694 (99.2) | 0.965 b | ||
| T/G | 80 (0.8) | 33 (0.8) | 47 (0.8) | ||||
| T/T | 2 (0.02) | 1 (0.02) | 1 (0.02) | ||||
| Allele | G | 19,736 (99.6) | 8301 (99.6) | 11,435 (9.6) | 0.942 a | ||
| T | 84 (0.4) | 35 (0.4) | 49 (0.4) | ||||
| rs397516878 | c.571T>C | p.F191L | Uncertain | ||||
| Genotype | A/A | 9899 (99.9) | 4163 (99.9) | 5736 (99.9) | 0.871 b | ||
| A/G | 11 (0.1) | 5 (0.1) | 6 (0.1) | ||||
| Allele | A | 19,809 (99.9) | 8331 (99.9) | 11,478 (99.95) | 0.871 b | ||
| G | 11 (0.1) | 5 (0.1) | 6 (0.05) | ||||
| rs76838169 | c.608T>C | p.I203T | Benign | ||||
| Genotype | A/A | 9298 (93.8) | 3929 (94.3) | 5369 (93.5) | 0.289 a | ||
| A/G | 598 (6.0) | 234 (5.6) | 364 (6.3) | ||||
| G/G | 14 (0.1) | 5 (0.1) | 9 (0.2) | ||||
| Allele | A | 19,194 (96.8) | 8092 (97.1) | 11,102 (96.7) | 0.122 a | ||
| G | 626 (3.2) | 244 (2.9) | 382 (3.3) | ||||
Abbreviations: SNPs, single nucleotide polymorphisms. a p values were estimated via chi-square test; b p values were estimated via Fisher’s exact test. p values in bold indicated statistical significance.
Table 3.
Characteristics and pure tone threshold of participants with the homozygous genotype of rs72474224 (c.109G>A) (n = 31).
Table 3.
Characteristics and pure tone threshold of participants with the homozygous genotype of rs72474224 (c.109G>A) (n = 31).
| Hearing Loss | Medical ID | Age (Years) | Gender | Better Ear (dB) | |||||
|---|---|---|---|---|---|---|---|---|---|
| 0.5 kHz | 1 kHz | 2 kHz | 4 kHz | 8 kHz | PTA 0.5–4 kHz | ||||
| Normal | 106846 | 58 | Female | 15 | 15 | 5 | 10 | 10 | 11.25 |
| Normal | 105802 | 59 | Female | 15 | 5 | 25 | 40 | 60 | 21.25 |
| Normal | 90678 | 68 | Male | 25 | 15 | 20 | 25 | 30 | 21.25 |
| Mild | 78353 | 60 | Male | 20 | 25 | 25 | 40 | 65 | 27.5 |
| Mild | 70091 | 61 | Female | 25 | 25 | 20 | 50 | 45 | 30 |
| Mild | 70740 | 61 | Female | 30 | 30 | 30 | 40 | 50 | 32.5 |
| Mild | 11011 | 63 | Female | 15 | 15 | 50 | 50 | 70 | 32.5 |
| Mild | 4888 | 64 | Female | 25 | 30 | 40 | 45 | 75 | 35 |
| Mild | 60195 | 64 | Female | 25 | 20 | 30 | 40 | 70 | 28.75 |
| Mild | 107326 | 64 | Female | 25 | 30 | 35 | 55 | 65 | 36.25 |
| Mild | 54382 | 66 | Male | 20 | 30 | 40 | 45 | 95 | 33.75 |
| Mild | 101181 | 66 | Male | 30 | 35 | 35 | 40 | 65 | 35 |
| Mild | 11321 | 67 | Male | 20 | 30 | 35 | 60 | 85 | 36.25 |
| Mild | 67746 | 69 | Female | 25 | 25 | 25 | 45 | 90 | 30 |
| Mild | 39311 | 71 | Male | 15 | 15 | 30 | 60 | 25 | 30 |
| Mild | 59571 | 74 | Female | 15 | 15 | 40 | 60 | 70 | 32.5 |
| Mild | 53680 | 76 | Male | 20 | 20 | 30 | 35 | 90 | 26.25 |
| Moderate | 54632 | 56 | Female | 35 | 35 | 35 | 60 | 90 | 41.25 |
| Moderate | 79049 | 61 | Female | 35 | 40 | 50 | 45 | 55 | 42.5 |
| Moderate | 16099 | 67 | Male | 20 | 30 | 60 | 70 | 85 | 45 |
| Moderate | 28532 | 67 | Male | 35 | 35 | 60 | 70 | 80 | 50 |
| Moderate | 90158 | 68 | Male | 40 | 50 | 50 | 65 | 55 | 51.25 |
| Moderate | 94371 | 68 | Male | 30 | 45 | 65 | 75 | 100 | 53.75 |
| Moderate | 42832 | 77 | Male | 15 | 30 | 60 | 70 | 90 | 43.75 |
| Moderate | 100741 | 77 | Female | 20 | 40 | 55 | 50 | 80 | 41.25 |
| Moderate | 116341 | 78 | Male | 40 | 40 | 50 | 60 | 85 | 47.5 |
| Moderate | 107144 | 79 | Male | 20 | 25 | 55 | 70 | 90 | 42.5 |
| Moderate | 5826 | 80 | Male | 40 | 50 | 65 | 85 | 90 | 60 |
| Severe | 56456 | 64 | Male | 50 | 55 | 65 | 90 | 110 | 65 |
| Severe | 115724 | 73 | Male | 60 | 70 | 70 | 75 | 110 | 68.75 |
| Severe | 93245 | 74 | Male | 60 | 60 | 70 | 70 | 100 | 65 |
Abbreviations: PTA, pure tone audiometry. Note: The homozygous genotype of rs72474224 (c.109G>A) is T/T.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Yuan, L.; Wang, X.; Liu, X.; Chen, S.; Kong, W.; He, M.; Sun, Y. Genotypic and Allelic Frequencies of GJB2 Variants and Features of Hearing Phenotypes in the Chinese Population of the Dongfeng-Tongji Cohort. Genes 2023, 14, 2007. https://doi.org/10.3390/genes14112007
AMA Style
Yuan L, Wang X, Liu X, Chen S, Kong W, He M, Sun Y. Genotypic and Allelic Frequencies of GJB2 Variants and Features of Hearing Phenotypes in the Chinese Population of the Dongfeng-Tongji Cohort. Genes. 2023; 14(11):2007. https://doi.org/10.3390/genes14112007
Chicago/Turabian StyleYuan, Lanlai, Xiaohui Wang, Xiaozhou Liu, Sen Chen, Weijia Kong, Meian He, and Yu Sun. 2023. "Genotypic and Allelic Frequencies of GJB2 Variants and Features of Hearing Phenotypes in the Chinese Population of the Dongfeng-Tongji Cohort" Genes 14, no. 11: 2007. https://doi.org/10.3390/genes14112007
APA StyleYuan, L., Wang, X., Liu, X., Chen, S., Kong, W., He, M., & Sun, Y. (2023). Genotypic and Allelic Frequencies of GJB2 Variants and Features of Hearing Phenotypes in the Chinese Population of the Dongfeng-Tongji Cohort. Genes, 14(11), 2007. https://doi.org/10.3390/genes14112007
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
